Professor of Medicine, Cleveland Clinic Lerner College of Medicine and Taussig Cancer Center
Radiation Oncology
Dr. Roger M. Macklis, MD
|
|
Give Review
Roger Macklis works in the field of Radiation Oncology. He attended Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He over the years received 9 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Northern Ohio Live", "ASTRO/ESTRO Exchange Fellowship", "American Cancer Society Junior Faculty Research Award", "ASTRO Resident Research Award", "ASCO Young Investigator Award" and "Medical degree awarded with thesis honors in a special field (Hematology/Oncology)". Roger Macklis is a published physician. He has 100 papers published. The most current publication "Brief courses of palliative radiotherapy for metastatic bone pain: a pilot cost-minimization comparison with narcotic analgesics."
Publications
- Impact of postmastectomy radiation on locoregional recurrence in Breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
- Dosimetric Benefit of a New Ophthalmic Radiation Plaque.
- Plaque brachytherapy for uveal melanoma: a vision prognostication model.
- Finally, a substantial role for radiotherapy in melanoma.
- ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
- 'Vitamin R' and its younger siblings.
- Regulation of CD20 expression by radiation-induced changes in intracellular redox status.
- Radioimmunotherapy as a therapeutic option for Non-Hodgkin's Lymphoma.
- Clinical Radioimmunotherapy and Systemic Targeted Radiopharmaceutical Therapy (STaRT) programs in a radiation oncology environment.
- Radioimmunotherapy for non-Hodgkin's Lymphoma: a review for radiation oncologists.
- Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.
- Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
- Radioimmunotherapy in a radiation oncology environment: building a multi-specialty team.
- Iodine-131 tositumomab (Bexxar) in a radiation oncology environment.
- Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy.
- Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate Cancer and myeloma cell lines.
- How and why does radioimmunotherapy work?
- TRAIL induction by radiation in Lymphoma patients.
- Portrait of Science. Scientist, technologist, proto-feminist, superstar.
- Radiotherapeutic errors and computerized record/verify systems.
- Image-guided radiation therapy in Lymphoma management. The increasing role of functional imaging.
- Introduction to radiotherapy and standard teletherapy techniques.
- E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.
- The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunct...
- Fluoroscopic study of tumor motion due to breathing: facilitating precise radiation therapy for lung Cancer patients.
- Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation.
- Error rates in clinical radiotherapy.
- Brief courses of palliative radiotherapy for Metastatic bone pain: a pilot cost-minimization comparison with narcotic analgesics.
- The role of radiation therapy in the management of Wilms' tumor.
- Reducing scatter radiation to the contralateral Breast with a mobile, conformal shield during Breast cancer radiotherapy.
- Teletherapy: advanced techniques.
- Hidden perils of automation and its effect on error reduction.
- Successful conversion from a linear accelerator-based program to a Gamma Knife radiosurgery program: the Cleveland Clinic experience.
- Palliative radiotherapy.
- It's time medicine stopped burying its mistakes.
- Treatment of prognosis of primary Breast lymphoma: a review of 13 cases.
- Radiotherapy for pediatric genitourinary tumors. Its role and long-term consequences.
- Radiation therapy in pregnancy: risk calculation and risk minimization.
- Lymphoma and pregnancy.
- Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation.
- Ionizing radiation induces CD20 surface expression on human B cells.
- Promoting patient safety: is technology the solution?
- Contralateral Breast cancer risk.
- Induction of mutations by bismuth-212 alpha particles at two genetic loci in human B-lymphoblasts.
- Historical and phrenologic reflections on the nonmotor functions of the cerebellum: love under the tent?
- Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis.
- Analysis of cytotoxicity of 131I-labelled OC125 F(ab'')2 on human epithelial ovarian Cancer cell lines.
- Wilms' tumor patients with pulmonary metastases.
- Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
- Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic ...
- Lymphoid irradiation results in long-term increases in natural killer cells in patients treated for Hodgkin's disease.
- Atypical radiation toxicity in patients with classical Kaposi''s Sarcoma.
- Radiation hormesis.
- Radiation therapy: orbital tumors.
- F(ab')2 fragments versus intact antibody--an isodose comparison.
- Radithor and the era of mild radium therapy.
- Radioisotope-mediated purging in bone marrow transplantation.
- The radiotoxicology of Radithor. Analysis of an early case of iatrogenic poisoning by a radioactive patent medicine.
- Alpha particle radio-immunotherapy: animal models and clinical prospects.
- Radioimmunotherapy with alpha-particle-emitting immunoconjugates.
- Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid.
- Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: implications for radioimmunotherapy.
- Synthesis of hemoglobin F in adult simian erythroid progenitor-derived colonies.
- The palliative role of radiotherapy in the management of the Cancer patient.
- Trends in radiation oncology: a review for the nononcologist.
- The spatial accuracy of cellular dose estimates obtained from 3D reconstructed serial tissue autoradiographs.
- Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
- Recent experience with Wilms' tumor: 1978-1991.
- Modulation of radiation-induced apoptosis and G2/M block in murine T-Lymphoma cells.
- Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy.
- Image analysis for the study of radionuclide distribution in tissue sections.
- An update of pediatric radiation oncology.
- Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in Lymphoma cells.
- Morphological, biochemical, and molecular changes in endothelial cells after alpha-particle irradiation.
- Radiobiologic studies of low-dose-rate 90Y-Lymphoma therapy.
- The great radium scandal.
- G2M arrest and apoptosis in murine T Lymphoma cells following exposure to 212Bi alpha particle irradiation.
- Internal dosimetry using data derived from autoradiographs.
- Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents.
- Magnetic healing, quackery, and the debate about the health effects of electromagnetic fields.
- Posterior mediastinal masses.
- Phenotypic and functional analysis of expanded natural killer cell subpopulations in Hodgkin''s disease patients treated with lymphoid irradiation.
- Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
- Review of clinical radioimmunotherapy.
- Convergence technology in Cancer medicine.
- Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin''s Lymphoma.
- Low dose irradiation for diffuse choroidal hemangioma.
- Review of image-guided radiation therapy.
- Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hem...
- 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
- Murine hematopoietic ablation by alpha-particle-emitting radiopharmaceuticals - a potential preparative regimen for bone-marrow transplantation.
- Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.
- Breast cancer radiotherapy: safe for all?
- Sequence of the 16 S-23 s spacer region in two ribosomal RNA operons of Escherichia coli.
- Radiosensitization of malignant melanoma--I. The effect of 7-hydroxy-chlorpromazine on the in vivo radiation response of Fortner''s melanoma.
- Intensity-modulated radiotherapy: rethinking basic treatment planning paradigms.
- Accommodating modern Cancer treatment procedures in an outpatient facility.
- A mobile shield to reduce scatter radiation to the contralateral Breast during radiotherapy for Breast cancer: preclinical results.
- Palliative radiotherapy for skeletal metastases: cost-substitution analyses and economic impact.
Schools
Harvard Medical School
Brigham Womens Hospital
Joint Center Rad Therapy
Dana Farber Canc Institute
Yale University
Procedures Preformed
- Bone Marrow Transplant
- Cancer Treatment
- Radiation Oncology Procedures
- Radio-Immunotherapy
Conditions Treated
- Breast Cancer
- Lymphoma
- Metastatic Cancer
- Sarcoma
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Access Choice PPO
- Blue Preferred HMO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Group Plan PPO
- EBS-RMSCO
- First Health (Coventry Health Care) PPO
- Frontpath Health Coalition
- Golden Rule
- GEHA
- Medicare Advantage PFFS
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Paramount
- TriCare for Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
- UPMC Health Plan
- Wells Fargo Insurance
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Northern Ohio Live
- ASTRO/ESTRO Exchange Fellowship
- American Cancer Society Junior Faculty Research Award
- ASTRO Resident Research Award
- ASCO Young Investigator Award
- Medical degree awarded with thesis honors in a special field (Hematology/Oncology)
Education
-
Brigham and Women's Hospital -
Harvard Medical School -
Yale University
Hospital
-
Cleveland Clinic
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457315103 |
| Last Name Of The Provider | MACKLIS |
| First Name Of The Provider | ROGER |
| View All |
Similar Doctors
|
|
Dr. Suzan S. Cheng, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yuji Seo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adir Ludin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas S. Galanopoulos, MD
This Doctor is OpenDoctor Recommended.
|